Abstract
Background Suicide risk assessment is a critical skill for mental health professionals (MHPs), yet traditional training in this area is often limited. This study examined the potential of generative artificial intelligence (GenAI)-based simulator to enhance self- efficacy in suicide risk assessment among MHPs.
Method A quasi-experimental study was conducted with 43 MHPs from Israel. Participants attended an online seminar and interacted with a GenAI-powered suicide risk assessment simulator. They completed pre- and post-intervention questionnaires measuring suicide risk assessment self-efficacy and willingness to treat suicidal patients. Qualitative data on user experience were collected.
Results We found a significant increase in self-efficacy scores following the intervention. Willingness to treat patients presenting suicide risk increased slightly but did not reach significance. Qualitative feedback indicated that participants found the simulator engaging and valuable for professional development. However, participants raised concerns about over-reliance on AI and the need for human supervision during training.
Conclusion This preliminary study suggests that GenAI-based simulators hold promise as a tool to enhance MHPs’ competence in suicide risk assessment. However, further research with larger samples and control groups is needed to confirm these findings and address ethical considerations surrounding AI use in suicide risk assessment training. AI-powered simulation tools have the potential to democratize access to high-quality training in mental health, potentially contributing to global suicide prevention efforts. However, their implementation should be carefully considered to ensure they complement rather than replace human expertise.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of The Max Stern Yezreel Valley College gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Financial and Material Support This research was supported by
Declaration of Relevant Financial Interests The authors declare the following potential
conflicts of interest: ’None’.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
